However, arguing against this indirect model, other immunohistochemical analyses have shown that higher levels of ESRP1 protein correlate with a shorter time to prostate cancer biochemical recurrence independent of ERG translocation status [14]. The gene discussed is ERG; the disease is prostate carcinoma.